FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely pharmacology, and can be applied in the pathological conditions associated with muscular dystrophy.
EFFECT: invention represents hyaluronidase, applied as an anabolic agent; invention ensures widening the range of medical products applied as anabolics.
4 ex, 4 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD OF INTENSIFICATION OF STEM CELLS MOBILISATION | 2006 | 
 | RU2330674C1 | 
| METHOD OF MYELOPOIESIS STIMULATION | 2007 | 
 | RU2336899C1 | 
| METHOD OF INCREASING STEM CELLS MOBILIZATION | 2009 | 
 | RU2442601C2 | 
| METHOD OF MYELOPOIESIS STIMULATION | 2008 | 
 | RU2366452C1 | 
| METHOD FOR PREPARING CELL TRANSPLANTATION MATERIAL IN MYELOSUPPRESSION | 2008 | 
 | RU2392947C1 | 
| EXPERIMENTAL TOXIC CHRONIC HEPATITIS TREATMENT METHOD | 2009 | 
 | RU2392000C1 | 
| AGENT INTENSIFYING ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES AND DRUGS | 2009 | 
 | RU2421239C1 | 
| HEMOSTIMULANT AND EXCITANT AND METHOD FOR HEMOPOIESIS STIMULATION | 2009 | 
 | RU2414926C1 | 
| METHOD FOR CORRECTING AFFECTED ERYTHROPOIESIS AT EXPERIMENTAL HYPOXIA | 2005 | 
 | RU2285300C1 | 
| TISSUE REGENERATION STIMULATING AGENT | 2013 | 
 | RU2599289C2 | 
Authors
Dates
2010-01-10—Published
2008-09-23—Filed